Alpha-fodrin is cleaved by caspase-3 in a chronic ocular hypertensive (COH) rat model of glaucoma

N G Tahzib1, N L Ransom, H A Reitsamer

  • 1Department of Ophthalmology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, Mail Code 6230, San Antonio, TX 78229-3900, USA.

Abstract

Insights

Caspase-3 cleaves alpha-fodrin in rat retinas, a process reduced by baculovirus inhibitory repeat-containing 4 (BIRC4). This finding suggests a potential therapeutic window for inhibiting apoptosis in glaucoma.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Ophthalmology

Background:

  • Alpha-fodrin is a neuronal cytoskeletal protein.
  • Alpha-fodrin is a known target of caspase-3.
  • Caspase-3 activation is implicated in neuronal apoptosis.

Purpose of the Study:

  • To determine if caspase-3 cleaves alpha-fodrin in ocular hypertensive rat retinas.
  • To investigate if adeno-associated virus (AAV)-mediated expression of baculovirus inhibitory repeat-containing 4 (BIRC4) reduces alpha-fodrin cleavage in these retinas.

Main Methods:

  • Ocular hypertension was induced in rat eyes via limbal injection of hypertonic saline.
  • Some eyes were pre-treated with intravitreal AAV-BIRC4 to inhibit caspase-3.
  • Western immunoblotting was used to analyze retinal samples for alpha-fodrin cleavage.

Main Results:

  • Caspase-3 cleavage of alpha-fodrin produces a distinct 120kDa fragment.
  • Significantly increased alpha-fodrin cleavage was observed in ocular hypertensive retinas compared to controls.
  • BIRC4 treatment significantly reduced caspase-3-mediated alpha-fodrin cleavage.

Conclusions:

  • Confirms caspase-3 mediated alpha-fodrin cleavage in ocular hypertensive rat retinas.
  • This cleavage process mirrors neuronal pathology in Alzheimer's disease.
  • Suggests a potential therapeutic window for caspase inhibitors like BIRC4 in treating glaucoma by inhibiting delayed retinal ganglion cell apoptosis.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...